Skip to main content

Table 3 Correlation of GATA gene expression level with overall survival in ovarian can cer patients with different clinical stage

From: Distinct expression and prognostic values of GATA transcription factor family in human ovarian cancer

GATA family Affymetrix ID clinical stage Cases HR 95% CI p-value
GATA-1 210446_at I 56 0.66 0.26-1.69 0.38
   II 324 0.81 0.58-1.13 0.20
   III 1015 0.89 0.74-1.07 0.21
   IV 20 0.37 0.10-1.35 0.12
GATA-2 207954_at I 56 0.60 0.19-1.87 0.38
   II 324 0.83 0.61-1.13 0.24
   III 1015 0.78 0.65-0.94 0.0083
   IV 20 0.64 0.22-1.88 0.41
GATA-3 209603_at I 56 7.64 1.01-57.67 0.02
   II 324 1.36 0.98-1.89 0.066
   III 1015 1.15 0.98-1.36 0.095
   IV 20 1.65 0.64-4.27 0.29
GATA-4 205517_at I 74 4.28 0.55-33.2 0.13
   II 61 0.34 0.11-1.03 0.045
   III 1044 0.81 0.68-0.96 0.017
   IV 176 1.30 0.82-2.05 0.26
GATA-5 238095_at I 41 4.12 1.30-12.99 0.0088
   II 162 0.77 0.47-1.24 0.27
   III 392 0.75 0.58-0.96 0.022
   IV 18
GATA-6 210002_at I 56 1.65 0.63-4.31 0.30
   II 324 1.24 0.89-1.72 0.20
   III 1015 1.41 1.19-1.67 6e-05
   IV 20 6.38 1.75-23.20 0.0017
TRPS1 218502_s_at I 56 1.80 0.70-4.66 0.22
   II 324 1.33 0.98-1.80 0.068
   III 1015 1.12 0.94-1.34 0.21
   IV 20 2.79 0.77-10.05 0.10
  1. Notes: The bold values indicate that the results are statistically significant
  2. Abbreviations: HR Hazard ratio, CI Confidence interval